Compare CPB & NOVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CPB | NOVT |
|---|---|---|
| Founded | 1869 | 1968 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Industrial Machinery/Components |
| Sector | Consumer Staples | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.6B | 5.7B |
| IPO Year | 1994 | 1999 |
| Metric | CPB | NOVT |
|---|---|---|
| Price | $22.04 | $143.55 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 18 | 1 |
| Target Price | $26.06 | ★ $144.00 |
| AVG Volume (30 Days) | ★ 9.7M | 530.3K |
| Earning Date | 06-01-2026 | 05-11-2026 |
| Dividend Yield | ★ 7.63% | N/A |
| EPS Growth | ★ 6.35 | N/A |
| EPS | ★ 1.55 | 0.51 |
| Revenue | ★ $10,253,000,000.00 | $521,290,000.00 |
| Revenue This Year | N/A | $8.61 |
| Revenue Next Year | $0.11 | $6.57 |
| P/E Ratio | ★ $14.28 | $291.39 |
| Revenue Growth | 6.40 | ★ 35.49 |
| 52 Week Low | $19.56 | $98.27 |
| 52 Week High | $34.18 | $171.85 |
| Indicator | CPB | NOVT |
|---|---|---|
| Relative Strength Index (RSI) | 50.21 | 40.85 |
| Support Level | $20.16 | $131.26 |
| Resistance Level | $22.85 | $149.42 |
| Average True Range (ATR) | 0.82 | 7.90 |
| MACD | -0.08 | -1.35 |
| Stochastic Oscillator | 29.15 | 5.97 |
Over the past 150-plus years, Campbell's has evolved into a leading domestic packaged food manufacturer, with a portfolio that extends beyond its iconic red-and-white labeled canned soup. In fiscal 2025 (July year-end), snacks accounted for 43% of its revenue, followed by soup (27%), other simple meals (23%), and beverages (7%). Beyond its namesake, its brands include Pepperidge Farm, Goldfish, Snyder's of Hanover, Swanson, Pacific Foods, Prego, Pace, V8, and, most recently, Rao's (a deal that closed in 2024). Around 90% of its revenue results from the US and the remainder from Canada and Latin America.
Novanta Inc supplies core technology solutions to medical, life science, and advanced industrial OEMs, leveraging proprietary expertise in precision medicine, precision manufacturing, robotics and automation, and advanced surgery. It has two segments: Automation Enabling Technologies and Medical Solutions. Automation Enabling Technologies, which generates the majority of revenue, provides laser beam steering and scanning solutions, laser sources, and robotic and precision motion technologies. The Medical Solutions segment provides medical-grade technologies, including medical insufflators, endoscopic pumps, and integrated operating room technologies. The company operates in the United States, Germany, and other markets, with revenue generated from the United States.